BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck

02 July, 2026 | Analysis

Can APAC Build Radioligand Therapy Before the Atoms Decay?

02 July, 2026 | Analysis

Samsung Biologics Accelerates Sustainability Strategy with Stronger ESG Performance

02 July, 2026 | News

METiS TechBio Signs US$1.62 Billion Licensing Deal for AI-Designed Cancer Therapy with Boulevard Bio

02 July, 2026 | News

BASF and Bota Biosciences Launch AI-Developed Recombinant Collagen Ingredient for Premium Skincare

02 July, 2026 | News

Shantha Biologics Signs Fill-Finish Manufacturing Agreement with Novo Nordisk in India

02 July, 2026 | News

Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck

THE GATE The choke point nobody puts on the slide Somewhere in the region this quarter, a cell-and-gene developer has everything the pitch deck promised. The Phase I data is clean. Patients are enrolled. A re...

Lab

01 July, 2026 | Wednesday | News

Colossal Foundation and University of Tasmania Partner to Fight Deadly Tasmanian Devil Cancer with Gene Editing and Vaccines

The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines across Tasmani...

BioTech

02 July, 2026 | Thursday | Analysis

Can APAC Build Radioligand Therapy Before the Atoms Decay?

Every dose of radioligand therapy is a countdown. The moment a batch of lutetium-177 leaves the reactor, it begins to fade — roughly half its therapeutic punch gone in under seven days. By the time those ...

Contract Services

02 July, 2026 | Thursday | News

Samsung Biologics Accelerates Sustainability Strategy with Stronger ESG Performance

Advanced environmental performance through renewable energy transition and enhanced carbon transparency Strengthened sustainability management and supply chain engagement across the healthcare value chain ...

Consumer Health

02 July, 2026 | Thursday | News

ALR Technologies Expands Diabetes Device Business with CGM Medical Acquisition

ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces it has entered into a Letter of Intent ("LOI") to acquire 100% equity of CGM Medical Technology Singapo...

Medtech

02 July, 2026 | Thursday | News

Inductive Bio Brings AI-Powered ADMET Prediction Models to Claude via New MCP Connector

Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, announced that it has joined Anthropic’s life sciences ecosystem and launched a Model Context Protocol (MCP) connector that m...

Cell & Gene

02 July, 2026 | Thursday | Analysis

Icosagen Completes €45 Million Expansion to Deliver End-to-End Biologics Development and GMP Manufacturing at a Single Site

Biopharma APAC Infomercial

Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck

Can APAC Build Radioligand Therapy Before the Atoms Decay?

Samsung Biologics Accelerates Sustainability Strategy with Stronger ESG Performance

METiS TechBio Signs US$1.62 Billion Licensing Deal for AI-Designed Cancer Therapy with Boulevard Bio

BASF and Bota Biosciences Launch AI-Developed Recombinant Collagen Ingredient for Premium Skincare

Shantha Biologics Signs Fill-Finish Manufacturing Agreement with Novo Nordisk in India

Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck

Colossal Foundation and University of Tasmania Partner to Fight Deadly Tasmanian Devil Cancer with Gene Editing and Vaccines

Can APAC Build Radioligand Therapy Before the Atoms Decay?

Samsung Biologics Accelerates Sustainability Strategy with Stronger ESG Performance

ALR Technologies Expands Diabetes Device Business with CGM Medical Acquisition

Inductive Bio Brings AI-Powered ADMET Prediction Models to Claude via New MCP Connector

Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck

Can APAC Build Radioligand Therapy Before the Atoms Decay?

Waters and IMU Biosciences Partner to Advance AI-Powered High-Definition Immune Profiling

Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck

Icosagen Completes €45 Million Expansion to Deliver End-to-End Biologics Development and GMP Manufacturing at a Single Site

Stay Connected